VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $447.034 thousand which missed the analyst consensus estimate of $765.167 thousand by 41.58 percent. This is a 133.25 percent increase over sales of $191.657 thousand the same period last year.